bpc 157 vs hgh Peptide Therapy for Pain Management and Healing BPC-157 Weight Loss: Evidence &

Description

doi: 10.1111/papr.12328

Retrieved 24 May 2022

From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies

How They Work Support hepatic fat metabolism via MIC compounds Deliver nutrients at 100% IM absorption Support liver function and fat export Inositol sensitizes insulin signaling B12 restores metabolic energy foundation Best results as part of a broader protocol What Patients Report Improved energy levels often from week 1 Reduced afternoon fatigue Improved exercise capacity and recovery Reduced carbohydrate cravings (inositol) More consistent weight management progress Results vary with diet, exercise, and baseline How They Differ GLP-1: appetite suppression + glucose regulation Lipotropic: fat metabolism + liver function Not competitive different mechanisms Commonly combined for complementary support B12 addresses fatigue GLP-1 patients experience Inform your NP of all current medications Benefits of B12 & Lipotropic Injections